LB Pharmaceuticals, Inc. (LBRX) Stock Statistics & Valuation Metrics

LB Pharmaceuticals, Inc. has a market cap or net worth of $1.54B. The enterprise value is $655.55.

LB Pharmaceuticals, Inc. has 32,259,174 shares outstanding. The number of shares has decreased by -2.65% in one year.

LB Pharmaceuticals, Inc.’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -9.93%.

The current PE Ratio of LB Pharmaceuticals, Inc. is ―. LB Pharmaceuticals, Inc.’s PEG ratio is 0.24.

In the last 12 months, LB Pharmaceuticals, Inc. had revenue of 0.00 and earned -25.20M in profits. Earnings per share was -1.00.

In the last 12 months, operating cash flow was -82.39M and capital expenditures -435.00K, giving a free cash flow of -82.83M billion.

LB Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

LB Pharmaceuticals, Inc. upcoming earnings date is Nov 5, 2026, Before Open (Confirmed).

LB Pharmaceuticals, Inc. as a current ratio of 41.44, with Debt / Equity ratio of 1.57%

In the past 12 months, LB Pharmaceuticals, Inc. has paid 1.00K in taxes.

LB Pharmaceuticals, Inc. EV to EBITDA ratio is -12.72, with an EV/FCF ratio of -8.98.

LB Pharmaceuticals, Inc. has $327.79M in cash and marketable securities with $5.22M in debt, giving a net cash position of $322.57M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for LB Pharmaceuticals, Inc. is $56.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy